Litigation Details for Millennium Pharmaceuticals Inc. v. Pharmascience Inc. (D. Del. 2015)
✉ Email this page to a colleague
Millennium Pharmaceuticals Inc. v. Pharmascience Inc. (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-08-13 |
Court | District Court, D. Delaware | Date Terminated | 2019-10-17 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Parties | PHARMASCIENCE INC. | ||
Patents | 6,713,446; 6,958,319 | ||
Attorneys | Neal C. Belgam | ||
Firms | Smith, Katzenstein, & Jenkins LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Millennium Pharmaceuticals Inc. v. Pharmascience Inc.
Details for Millennium Pharmaceuticals Inc. v. Pharmascience Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-06-10 | 20 | Millennium's drug patents: U.S. Patent Nos. 6,713,446 (the "'446 patent") and 6,958,319…Injec~ion before the expiration of U.S. Patent Nos. 6,713,446 and 6,958,319." (Id.) Millennium asserts…6,958,319 (the "'319 patent"). (Id.) Presently before the court is PSI's motion to dismiss…exclusive licensee of the '446 and '319 patents, which are listed in the FDA's "Orange…certification" that the '446 and '319 patents were invalid, unenforceable or would not be infringed | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |